A clinical pathway primarily for pediatric patients at risk of vitamin D deficiency. Covers risk-based screening, 25-hydroxyvitamin D testing, interpretation of laboratory results, supplementation by age and weight status, follow-up, prevention, and endocrinology referral. Includes frequently asked questions, education resources, a sample laboratory test review letter, references, and clinical improvement team details. Originated November 3, 2014; last reviewed or revised August 25, 2020.
Free preview text
The first 5 pages, shown as text so search engines and readers can find this document.
Page 1
CLINICAL PATHWAY
Page 1 of 12
VITAMIN D DEFICIENCY
ALGORITHM
Assess patient’s risk for
vitamin D deficiency
Is the patient at
an increased risk?
Obtain 25-hydroxy
vitamin D lab evaluation
• Repeat yearly diet/high risk
screening
• Consider maintenance
dosing
Were the results
low?
• Start supplementation based
on dosing recommendations.
• Repeat 25-hydroxy vitamin D
lab assessment in 6-12 weeks
Were the results
low?
• Confirm adequate dose
• Check for adherence
• Consider increasing dose
• Repeat 25-hydroxy vitamin D
lab assessment in 6-12 weeks
Were the results
low?
Improved but low Persistent low
Consider endocrinologist
evaluation
Normal
Normal
Normal
Yes
Yes
Yes
Yes
Repeat yearly diet/high risk
screening
No
Inclusion Criteria
• Patients with risk factors for low
vitamin D levels
Exclusion Criteria
• Patients with conditions that may
require large doses and frequent
follow up
• Patients with rickets or
hypercalcemia
• Confirm adequate dose
• Check for adherence
• Consider increasing dose
• Repeat 25-hydroxy vitamin D
lab assessment in 6-12 weeks
Check for adherence
Patient risk factors:
• Dark, covered skin, limited sun exposure
• Low dietary intake
• Exclusively breast fed infants (see specifics)
• Premature birth
• Chronic use of medications (see list)
• Malabsorption problems
• Liver failure, Chronic renal disease
• Obesity (BMI greater than 95th percentile)
• Osteoporosis /Low bone density
Dosing chart:
Lab results severity:
• Severe Deficiency = Less than 12 ng/mL
• Deficiency =13 to 19 ng/mL
• Insufficiency = 20 to 29 ng/mL
Page 2
CLINICAL PATHWAY
Page 2 of 12
PATHWAY SUMMARY
Assessment
Consider vitamin D screening in children with the following risk factors:
• Dark or covered skin
• Limited sun exposure
• Low dietary intake
• Any breast-fed or formula-fed infant unable to consume at least 1L/day of fortified breastmilk or formula, who is
not already supplemented with the recommended Vitamin D dose (400 IU/10 mcg)
• Chronic use of medications that impact vitamin D metabolism or absorption, or greatly increase risk of
osteoporosis: including anticonvulsants, glucocorticoids, antifungals and medications used for the treatment of
HIV
• Malabsorption problems
• Liver failure
• Obesity (BMI >95th percentile)
• Premature birth
• Chronic renal disease or history of renal transplant
• Osteoporosis
• Low bone density
Laboratory Study
• Request for 1,25-dihydroxyvitamin D will be intercepted by the team and the provider form letter will be sent to
the ordering provider
Therapeutics
• The Children’s Hospital Colorado Vitamin D Committee recommends that all individuals, who are supplemented,
take once-daily vitamin D3 or its weekly equivalent to maintain serum 25(OH)D levels of at least 30 ng/mL.
Recommendations for follow up:
• Vitamin D levels should be rechecked after 6 to12 weeks of treatment.
• Vitamin D can be evaluated sooner if medically indicated.
• Consider annual surveillance in individuals that remain at-risk for vitamin D deficiency or when optimization of
vitamin D status is a treatment goal for bone health.
• Consider Endocrinology referral if deficiency is resistant to treatment, or in patients with osteoporosis and low
bone density.
Prevention
Information regarding appropriate sun exposure, the use of vitamin D supplements, and eating a diet rich in calcium
and vitamin D should be made available to each patient.
Page 3
CLINICAL PATHWAY
Page 3 of 12
TABLE OF CONTENTS
Algorithm
Target Population
Background | Definitions
Initial Evaluation – see Recommendation for Screening
Laboratory Studies | Imaging
Therapeutics
Prevention
Frequently Asked Questions
Parent | Caregiver Education
Appendix A. Sample Laboratory Request Letter
References
Clinical Improvement Team
TARGET POPULATION
Inclusion Criteria
• Patients with risk factors for low vitamin D levels
Exclusion Criteria
• Pediatric patients with chronic medical conditions which may require large doses and more frequent follow up.
• Patients with severe deficiency leading to rickets or other conditions associated with hypercalcemia.
BACKGROUND | DEFINITIONS
Vitamin D is a fat-soluble vitamin that the body makes from cholesterol through the action of the sun’s UVB rays on the
skin. Factors such as skin color, age, amount and time of sun exposure, and geographic location affect how much
vitamin D the body makes. The primary function of vitamin D is to maintain normal blood concentrations of calcium and
phosphorus, to support bone health as normal bone mineralization depends on adequate calcium and phosphate1 Low
vitamin D levels may result in decreased calcium and phosphate concentrations, and secondary hyperparathyroidism
causing inadequate mineralization and loss of skeletal mass. When growth plates are closed, this can lead to
osteomalacia; if the growth plates have not closed, rickets may develop. It has also been suggested that vitamin D
may have additional benefits on cardiovascular, pancreatic, muscle and brain health.
RECOMMENDATION FOR SCREENING
Note: Screening for vitamin D levels should be reserved for patients with risk factors for deficiency or when
optimization of vitamin D is a treatment goal for bone health. Universal screening of all patients is not recommended2,3.
Consider assessing vitamin D status in children with the following risk factors:
• Dark skin1
• Limited sun exposure, including frequent sunscreen use and cultural convention associated with covering body3
• Low dietary intake, including vegan/macrobiotic diets, milk avoiders or patients with allergy/intolerance3
Page 4
CLINICAL PATHWAY
Page 4 of 12
• Chronic use of medications that impair vitamin D metabolism or absorption (e.g. anticonvulsants, steroids
[including inhaled], antifungals and medications used for the treatment of HIV)2
• Malabsorption problems (including celiac disease, cystic fibrosis, etc.)2
• Obesity1 (95th percentile)
• Premature birth3
• Infants of breastfeeding mothers with dark skin or covered (minimal skin exposure) without vitamin D
supplementation or low intake of foods containing vitamin D. Any breast-fed or formula-fed infant unable to
consume at least 1L/day of fortified breastmilk or formula is at increased risk of vit D deficiency 3.
• Malabsorption problems
• Chronic renal disease or history of renal transplant
• Liver failure
• Chronic renal disease or history of renal transplant
• Osteoporosis
• Low bone density
LABORATORY STUDIES
Vitamin D levels are measured by total serum 25-hydroxyvitamin D [also referred to as 25(OH)D]2. Testing 25-
hydroxyvitamin D is most useful in nutrition assessment, primarily due to its longer half-life and minimal effect of
parathyroid hormone on circulating levels.
Since the development of 1,25-dihydroxyvitamin D testing, proper utilization based on clinical need has been
problematic. The circulating half-life of 1,25-dihydroxyvitamin D is relatively short, which limits utility for overall vitamin
D assessment. 1,25-dihydroxyvitamin D testing can be useful in the diagnosis of renal dysfunction in conjunction with
parathyroid hormone, as well as in specific disorders of mineral metabolism.
Laboratory Approval Process
Test requests for 1,25-dihydroxyvitamin D will be flagged for review by the lab and sent to the ordering provider for
review.
• Laboratory team responsibility:
o Request for 1,25-dihydroxyvitamin D will be intercepted by the team and the provider form letter will be sent to
the ordering provider.
o After the ordering provider responds with their decision, the lab team will either:
o Send the specimen for processing
OR
o Cancel the request and redirect, to 25(OH)D testing
• The lab team will document the case and decision in their database
• Provider responsibility:
o In the event the ordering provider does not respond within two days, the request will be sent to the on-call
provider for the group.
o The on-call provider can decide to approve the testing or redirect testing if clinically indicated
Page 5
CLINICAL PATHWAY
Page 5 of 12
Evaluation of Laboratory Results
• Vitamin D status as measured by 25(OH)D: (interpretation should take into account time of year, skin color,
and presence of obesity or medical condition)
• Severe Deficiency = Less than 12 ng/mL
o At-risk for rickets, defective bone mineralization, and fractures
• Deficiency =13 to 19 ng/mL
• Insufficiency = 20 to 29 ng/mL
o At-risk for secondary hyperparathyroidism and decreased bone mineral density
• Sufficiency = 30 to 100 ng/mL
• Toxicity = Greater than100 ng/mL
o Hypercalcemia
o Gastrointestinal distress, bone pain
o Hypercalciuria
o Kidney stones
o Hyperphosphatemia
THERAPEUTICS
Recommendations for supplementation:
These recommendations do not differentiate between the use of cholecalciferol (D3) or ergocalciferol (D2), as there is
insufficient data to show any significant difference in absorption, particularly at therapeutic levels5. For patients who
require large weekly doses (i.e., 50,000 International Units2) is preferred: however, it should be noted that patient
insurance may require prescription and prior authorization (PAR). The American Academy of Pediatrics recommends
daily dosing; however, the dosing schedule (daily versus weekly) should be individualized to minimize financial issues
and treatment burden, particularly in patients with chronic illness6. Other considerations include the potential for
vitamin D toxicity if a weekly high-dose regimen is inadvertently continued or possible loss of efficacy if the weekly
dose is missed. The Children’s Hospital Colorado Vitamin D Committee recommends that all individuals, who are
supplemented, take once-daily vitamin D3 or its weekly equivalent to maintain serum 25(OH)D levels of at least 30
ng/mL.
Table 1. Dosing Recommendations for Treatment
25(OH)D Level Daily dosing for children 0 to less
than 10 years of age
Daily dosing for patients 10 to 18 years of
age
Severe Deficiency: Less than 12
ng/mL
2000 International Units or 50 mcg
(normal weight)
4000 International Units or 100 mcg (normal
weight)
4000 International Units or 100 mcg
(obese, BMI > 95%)
8000 International Units or 200 mcg (obese,
BMI > 95%)
Deficiency: 13 to 19 ng/mL 1000 International Units or 25 mcg
(normal weight)
2000 International Units or 50 mcg (normal
weight)
2000 International Units or 50 mcg
(obese, BMI > 95%)
4000 International Units or 100 mcg (obese,
BMI > 95%)
Insufficiency: 20 to 29 ng/mL 400 to 800 International Units or 10
to 20 mcg (normal weight)
800 International Units or 20 mcg (normal
weight)
Vitamin D Deficiency Clinical Pathway: summary, contents and background
This guide helps you understand the scope of Vitamin D Deficiency Clinical Pathway before or alongside reading the original document. It is based on the catalogue record, credited creator, source, classification and topics shown on this page. It does not replace the original work and does not invent claims about passages that Doxxly cannot verify.
Summary and overview
Vitamin D Deficiency Clinical Pathway is a 12-page documentcredited to Orson H. Zephyr. A clinical pathway primarily for pediatric patients at risk of vitamin D deficiency. Covers risk-based screening, 25-hydroxyvitamin D testing, interpretation of laboratory results, supplementation by age and weight status, follow-up, prevention, and endocrinology referral. Includes frequently asked questions, education resources, a sample laboratory test review letter, references, and clinical improvement team details. Originated November 3, 2014; last reviewed or revised August 25, 2020. It appears in the Medicine & Wellbeing collection, which groups it with other material that readers may use for comparison and further study.
The item can be approached in several ways. A reader looking for a quick orientation can begin with the free five-page preview, inspect the page structure and use the metadata to judge relevance. Someone undertaking deeper research can work through the complete file, search its indexed text, record useful page references and compare its treatment of Clinical pathway, Vitamin D deficiency, Pediatrics, Nutrition, Bone health, Laboratory testing, Vitamin D supplementation, Preventive care with the related resources linked below.
Rather than reducing the work to a single claim, this page treats it as a source that should be read in context. The title, creator, publication source, licence and format all help explain what kind of evidence it may offer. Readers should distinguish the original author's statements from Doxxly's catalogue description, and should cite the original edition when using the material in academic, professional or published work.
Key topics and reader takeaways
The catalogue connects this document with Clinical pathway, Vitamin D deficiency, Pediatrics, Nutrition, Bone health, Laboratory testing, Vitamin D supplementation, Preventive care. These terms offer practical entry points rather than a substitute for close reading. Start by identifying the definitions, examples, arguments, tables or visual explanations attached to each topic. Then note where the creator draws connections, makes distinctions or moves from background material to a conclusion, recommendation, calculation or narrative development.
A useful reading method is to separate description from interpretation. First record what the item actually presents: names, headings, figures, formulas, quotations or stated propositions. Next consider why those details matter within the whole work. Finally compare them with another source from the same subject area. This process helps turn a long digital file into evidence that can be evaluated rather than merely skimmed.
Table of contents and reading guide
The following is an editorial content guide based on the verified catalogue topics. It is not represented as the original author's formal table of contents. Use it to organise notes while moving through the 12 pages in the player.
Part 1
Clinical pathway
Use this section of the reading guide to identify how Clinical pathway appears in Vitamin D Deficiency Clinical Pathway, note important terms, and connect the subject to the wider purpose of the work.
Part 2
Vitamin D deficiency
Use this section of the reading guide to identify how Vitamin D deficiency appears in Vitamin D Deficiency Clinical Pathway, note important terms, and connect the subject to the wider purpose of the work.
Part 3
Pediatrics
Use this section of the reading guide to identify how Pediatrics appears in Vitamin D Deficiency Clinical Pathway, note important terms, and connect the subject to the wider purpose of the work.
Part 4
Nutrition
Use this section of the reading guide to identify how Nutrition appears in Vitamin D Deficiency Clinical Pathway, note important terms, and connect the subject to the wider purpose of the work.
Part 5
Bone health
Use this section of the reading guide to identify how Bone health appears in Vitamin D Deficiency Clinical Pathway, note important terms, and connect the subject to the wider purpose of the work.
Part 6
Laboratory testing
Use this section of the reading guide to identify how Laboratory testing appears in Vitamin D Deficiency Clinical Pathway, note important terms, and connect the subject to the wider purpose of the work.
Part 7
Vitamin D supplementation
Use this section of the reading guide to identify how Vitamin D supplementation appears in Vitamin D Deficiency Clinical Pathway, note important terms, and connect the subject to the wider purpose of the work.
Part 8
Preventive care
Use this section of the reading guide to identify how Preventive care appears in Vitamin D Deficiency Clinical Pathway, note important terms, and connect the subject to the wider purpose of the work.
When a heading in the original differs from this guide, follow the original heading in your citation. Page numbers can also vary between editions. Doxxly's direct page field is useful for navigation, but formal references should include the title, creator, source and edition details available in the file itself.
About Orson H. Zephyr
Doxxly credits Orson H. Zephyr as the author or creator of Vitamin D Deficiency Clinical Pathway. This page does not add an unverified biography, job title or institutional affiliation. The attribution is preserved so readers can distinguish the creator from the hosting library and follow the original record when an external author link is available.
Author context matters because a work reflects a particular purpose, audience and point of view. Before relying on the material, consider what the creator set out to explain, when the source was produced and whether later research or revised guidance should also be consulted. For literature and philosophy, compare translations and editions; for technical material, check whether a newer version has superseded the one shown here.
About the source organisation
The recorded source for this item is childrenscolorado.org. Doxxly provides access and discovery tools but does not claim to be the original publisher unless explicitly stated. Source links, creator attribution and the recorded Publicly available file collected for editorial review licence are displayed to help readers assess provenance and permitted use.
Provenance is especially important for reports, standards, presentations and working spreadsheets. Check the original source for amendments, supporting files and current policy. A trustworthy research workflow keeps the source URL with any notes or downloaded copy, verifies important figures against the original, and avoids treating an archived document as automatically current.
Begin with the title and opening pages, then use the guide above to decide whether to read sequentially or move to a particular topic. The Doxxly player provides previous and next navigation, a direct page field, zoom steps, fit-to-width and fit-to-page modes, rotation and fullscreen. These controls are useful when a page contains small type, a wide table, an image, a scanned layout or a dense sequence of notes.
The first five pages are open to every visitor. A plan unlocks the complete item and full-document search. Search is best used for distinctive names, technical terms or short phrases; broad words can produce too many possible contexts. When you find a useful passage, read the surrounding pages so that a sentence, chart or formula is not separated from its explanation.
If downloading is enabled, members can obtain the original PDF file. Keep the original format when formulas, slide sequencing, pagination or layout carries meaning. Respect the Publicly available file collected for editorial review terms displayed on this page, and use the rights-report link if you believe the attribution or availability needs review.
Research questions to consider
As you read Vitamin D Deficiency Clinical Pathway, ask which audience the creator addresses, what problem or idea organises the work, what evidence is presented, and which assumptions remain unstated. Note whether important terms are defined consistently and whether examples represent a broader pattern or a narrow case. For quantitative material, record units, time periods, formulas and data sources. For interpretive material, separate the creator's language from your own summary.
A second set of questions concerns relevance today. Which parts remain durable, which depend on their historical or institutional setting, and what would need confirmation from a newer source? Following the tags and the Medicine & Wellbeing collection can reveal useful comparisons. Agreement between sources can strengthen confidence, while disagreement can point to changing definitions, methods, evidence or priorities.
Finally, decide what you need from the item: background knowledge, a quotation, a worked example, a model, a visual explanation or a starting bibliography. That purpose should guide the depth of reading and the notes you keep. Doxxly helps locate and navigate the source; careful interpretation remains the reader's responsibility.